Marker Therapeutics, Inc.

+1 (713) 400-6400

3200 Southwest Fwy #2240 Phoenix Tower
Houston, TX 77027

© 2020 Marker Therapeutics, Inc.

Tagged: vivo

Marker Therapeutics Announces Clinical Update at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019

February 25, 2019

Marker Therapeutics announces updated data from four clinical trials using the Company’s multi-antigen targeted T cell (MultiTAA) therapies.

Read More

Sign up for email alerts

Get Marker News Delivered To Your Inbox

Sign Up Today

© 2020 Marker Therapeutics, Inc.